... Lancet 1987; 1: 949– 951. 2 Bronster DJ, Emre S, Mor E, Sheiner P, Miller CM, Schwartz ME. Neurologic ...
Tópico(s): Neurosurgical Procedures and Complications
1995 - Wiley | Liver Transplantation and Surgery
Kengo Fukuzawa, Myron Schwartz, Eliezer Katz, EITAN MOR, Sukru Emre, Koray Acarli�, Charles M. Miller,
FUKUZAWA, KENGO; SCHWARTZ, MYRON E.; KATZ, ELIEZER; MOR, EITAN; EMRE, SUKRU; ACARLI, KORAY; MILLER, CHARLES M. Author Information
Tópico(s): Genetic and Kidney Cyst Diseases
1993 - Wolters Kluwer | Transplantation
Albert D. Min, Henry C. Bodenheimer,
... Sheiner PA, Fisher A, Schluger LK, Bodenheimer H, Mor E, Emre S, Schwartz ME, et al. Treatment with alpha- ...
Tópico(s): Transplantation: Methods and Outcomes
1995 - Lippincott Williams & Wilkins | Hepatology
Sukru Emre, Myron Schwartz, Eytan Mor, Keiji Kishikawa, Özgür Yağmur, Neil Thiese, Patricia A. Sheiner, Rahul M. Jindal, S. Chiodini, Charles M. Miller,
Liver allografts are traditionally rinsed with cold lactated Ringer's (LR) prereperfusion to clear K+-rich preservation solution from the hepatic vasculature. LR has been shown, however, to be injurious to the graft. By restoring portal blood flow without rinsing and discarding the initial blood traversing the liver (PB flush), we sought to eliminate rinsing without inducing hyperkalemia. Between August 1988 and December 1992, 481 OLTx were performed in 412 pts. Four rinsing methods were used sequentially: ...
Tópico(s): Liver Disease Diagnosis and Treatment
1994 - Wolters Kluwer | Transplantation
Rahul M. Jindal, I Popescu, S Emre, M. E. Schwartz, Patrizia Boccagni, P Meneses, Eytan Mor, P Scheiner, Crystal Miller,
Jindal, R M; Popescu, I; Emre, S; Schwartz, M E; Boccagni, P; Meneses, P; Mor, E; Scheiner, P; Miller, C M Author Information
Tópico(s): Lipid metabolism and biosynthesis
1994 - Wolters Kluwer | Transplantation
Adrian Fisher, Neil D. Theise, Albert D. Min, Eytan Mor, Sukru Emre, Adam Pearl, Myron Schwartz, Charles M. Miller, Patricia A. Sheiner,
The results of liver transplantation in patients with cholangiocarcinoma have been poor. It has been suggested that elevated serum CA19-9 levels predict cholangiocarcinoma in patients with primary sclerosing cholangitis. We analyzed the predictive value of CA19-9 antigen as a marker of cholangiocarcinoma in patients with primary sclerosing cholangitis evaluated for liver transplantation. We reviewed the charts of 26 patients with primary sclerosing cholangitis (stage IV) in whom preoperative serum ...
Tópico(s): Gallbladder and Bile Duct Disorders
1995 - Wiley | Liver Transplantation and Surgery
Emre Seli, Belgin Selam, Gil Mor, Umit A. Kayisli, Tugce Pehlivan, Aydin Arici,
Objective The protective effect of estrogen against early atherosclerosis in animal models is well documented, but the mechanisms responsible for this effect are not well understood. The earliest recognizable event in the pathogenesis of atherosclerosis is an increased recruitment of macrophages into the arterial subendothelium. Macrophages first play a protective role by removing low-density lipoproteins, but when the cholesterol is in excess, macrophages are converted into foam cells and form ...
Tópico(s): Chemokine receptors and signaling
2001 - Lippincott Williams & Wilkins | Menopause The Journal of The North American Menopause Society
Jérôme Dumortier, Sophie Bernard, Yves Bouffard, Olivier Boillot,
... 21: 572– 577. 3 Fisher A, Schwartz M, Mor E, Sheiner P, Emre S, Guy S, et al. Gastrointestinal toxicity associated ...
Tópico(s): Adenosine and Purinergic Signaling
2006 - Lippincott Williams & Wilkins | Liver Transplantation
Patricia A. Sheiner, Eytan Mor, Lawrence Chodoff, Sheldon Glabman, Sukru Emre, Myron Schwartz, Charles M. Miller,
SHEINER, PATRICIA A.; MOR, EYTAN; CHODOFF, LAWRENCE; GLABMAN, SHELDON; EMRE, SUKRU; SCHWARTZ, MYRON E.; MILLER, CHARLES M. Author Information
Tópico(s): Renal Transplantation Outcomes and Treatments
1994 - Wolters Kluwer | Transplantation
Eytan Mor, Audrey H. Schwersenz, Patricia A. Sheiner, Sukru Emre, Myron Schwartz, Charles M. Miller,
MOR, EYTAN; SCHWERSENZ, AUDREY; SHEINER, PATRICIA A.; EMRE, SUKRU; SCHWARTZ, MYRON E.; MILLER, CHARLES M. Author Information
Tópico(s): Pharmacological Effects and Toxicity Studies
1994 - Wolters Kluwer | Transplantation
Eytan Mor, Audrey H. Schwersenz, Patricia A. Sheiner, Sukru Emre, Myron Schwartz, Charles M. Miller,
MOR, EYTAN; SCHWERSENZ, AUDREY; SHEINER, PATRICIA A.; EMRE, SUKRU; SCHWARTZ, MYRON E.; MILLER, CHARLES M. Author Information
Tópico(s): Organ Transplantation Techniques and Outcomes
1994 - Wolters Kluwer | Transplantation
Jinyan Zhang, Weiguo Hu, Wei Xing, Tao You, Junming Xu, Xuebin Qin, Zhihai Peng,
... 1993; 25: 3031-3033PubMed Google Scholar, 3Katz E. Mor E. Patel T. Theise N. Emre S. Schwartz M.E. Miller C.M. Association ...
Tópico(s): Renal Transplantation Outcomes and Treatments
2011 - Elsevier BV | American Journal Of Pathology
John J. Lemasters, Hartwig Bunzendahl, Ronald G. Thurman,
... CASPubMedWeb of Science®Google Scholar 15 Katz E, Mor E, Patel T, Theise N, Emre S, Schwartz ME, et al. Association between preservation ...
Tópico(s): Liver Disease and Transplantation
1995 - Wiley | Liver Transplantation and Surgery
This commentary targets the core ideas of the composition-based view (CBV). First, we argue that the deployment of compositional capabilities (CCs) to combine ordinary resources fits the resource-based view (RBV) and that there is therefore no need for a CBV. Second, we argue that the CCs should be presented as a specific type of dynamic capability (DC). We show that even where ordinary resources are being combined, superior combinatory capabilities are needed as competitive advantage cannot otherwise ...
Tópico(s): Business Strategy and Innovation
2015 - Cambridge University Press | Management and Organization Review
Eytan Mor, PATRIZIA BOCCAGNI, Swan N. Thung, Patricia A. Sheiner, Sukru Emre, Stephen R. Guy, Myron Schwartz, Charles M. Miller,
MOR, EYTAN; BOCCAGNI, PATRIZIA; THUNG, SWAN N.; SHEINER, PATRICIA A.; EMRE, SUKRU; GUY, STEPHEN R.; SCHWARTZ, MYRON E.; MILLER, CHARLES M. Author Information
Tópico(s): Vascular Malformations and Hemangiomas
1995 - Wolters Kluwer | Transplantation
Patricia A. Sheiner, Eytan Mor, Lawrence Chodoff, Sheldon Glabman, Sukru Emre, Myron Schwartz, Charles M. Miller,
Tópico(s): Antibiotics Pharmacokinetics and Efficacy
1994 - Wolters Kluwer | Transplantation
Eytan Mor, Patricia A. Sheiner, Myron Schwartz, Sukru Emre, STEPHEN GUY, Charles M. Miller,
Tópico(s): Advanced Drug Delivery Systems
1994 - Wolters Kluwer | Transplantation
Raymond A. Vallera, Peter B. Cotton, Pierre‐Alain Clavien,
... orthotopic liver transplantation. Hepatology 1992; 16: 49. 23 Mor E, Schwartz ME, Sheiner PA, Menesses P, Hytiroglou P, Emre S. Prolonged preservation in University of Wisconsin solution ...
Tópico(s): Congenital Anomalies and Fetal Surgery
1995 - Wiley | Liver Transplantation and Surgery
E. Mor, T. Patel, Sheldon Glabman, Patricia A. Sheiner, Sukru Emre, Stephen R. Guy, Myron Schwartz, Charles M. Miller,
Tópico(s): Neurological Complications and Syndromes
1994 - Springer Science+Business Media | Transplant International
Patricia A. Sheiner, Péter Boros, Franklin M. Klion, Swan N. Thung, Leona Kim Schluger, Johnson Y.N. Lau, Eytan Mor, Carol Bodian, Stephen R. Guy, Myron Schwartz, Sukru Emre, Henry C. Bodenheer, Charles M. Miller,
Clinical recurrence of hepatitis C after liver transplantation can lead to cirrhosis, liver failure, and death. In patients undergoing liver transplantation for hepatitis C, we assessed the efficacy of interferon alfa-2b (IFN) in preventing recurrent hepatitis. We randomized 86 patients to either an IFN group (3 MU three times a week starting within 2 weeks after transplantation and continued for 1 year) or a control (no IFN) group. Recurrence, the primary end point, was diagnosed on biopsy performed ...
Tópico(s): Liver Disease and Transplantation
1998 - Lippincott Williams & Wilkins | Hepatology
To discuss the recent applications of electrophysiological principles to the optimization and automation of the IVF laboratory.There is growing evidence showing improvement of live birth rates following oocyte electro-activation. Novel applications using electrophysiological techniques are now employed to determine oocyte penetration and viability in real-time.In this short review, we summarize the recent advances in the integration of electrophysiological techniques into the assisted reproductive ...
Tópico(s): Pluripotent Stem Cells Research
2020 - Lippincott Williams & Wilkins | Current Opinion in Obstetrics & Gynecology
Eytan Mor, Myron Schwartz, Patricia A. Sheiner, PEDRO MENESSES, PRODROMOS HYTIROGLOU, Sukru Emre, KEIJI KISHIKAWA, STEFANO CHIODINI, Charles M. Miller,
Hepatic artery thrombosis (HAT) after liver transplantation (LTx) usually mandates retransplantation. Prolonged preservation with Eurocollins solution has been associated with HAT. We reviewed our experience with 359 LTx patients to identify risk factors for HAT. All grafts were preserved in University of Wisconsin solution. HAT developed in 12 patients (3%) within 50 days. Seven patients were asymptomatic; four presented with biliary sepsis and 1 with poor graft function. Two patients had suffered ...
Tópico(s): Transplantation: Methods and Outcomes
1993 - Wolters Kluwer | Transplantation
Eytan Mor, Donna Skerrett, Cosme Manzarbeitia, Patricia A. Sheiner, Myron Schwartz, Sukru Emre, Swan N. Thung, Charles M. Miller,
Graft and patient survival rates after transplantation of ABO-incompatible liver allografts have been poor. We used plasmapheresis and a potent immunosuppressive regimen to control hemagglutinin levels and prevent early rejection. Ten patients who had a United Network for Organ Sharing status of 4 received ABO-incompatible allografts. Quadruple immunosuppression consisted of OKT3, Cytoxan, cyclosporine, and steroid taper; prostaglandin E-1 was administrated intravenously the first week. All patients ...
Tópico(s): Transplantation: Methods and Outcomes
1995 - Wolters Kluwer | Transplantation
Patricia A. Sheiner, Myron Schwartz, Eytan Mor, Leona Kim Schluger, Neil D. Theise, Keiji Kishikawa, Vadim Kolesnikov, Henry C. Bodenheimer, Sukru Emre, Charles M. Miller,
Recurrent hepatitis C causes significant morbidity after liver transplantation. Because immunosuppression is associated with enhanced viral replication, we postulated that clinical recurrence of the disease may be associated with augmented immunosuppression for rejection. In 96 patients with hepatitis C who received liver transplants, we recorded the interval from transplantation to recurrence, the episodes of steroid-resistant rejection (SRR) requiring OKT3, the number of rejection episodes, and ...
Tópico(s): Liver Disease and Transplantation
1995 - Lippincott Williams & Wilkins | Hepatology
Gürbüz Gökçe, Neriman Mor, Ali Haydar KIRMIZIGÜL, Kadir Bozukluhan, Ekin Emre ERKILIÇ,
Tópico(s): Animal Disease Management and Epidemiology
2015 - BioMed Central | Israel journal of veterinary medicine
Media images of walls being erected or dismantled symbolize the global dilemma at the heart of the approach toward diversity during economically challenging times. Will communities, organizations, and nations become more isolated, exclusionary, and protective of scarce resources? Or will they embrace diversity for humanistic reasons and its potential to drive economic growth? This paper first critically examines the paradox of diversity and deems it false because it omits the important role of inclusion ...
Tópico(s): Entrepreneurship Studies and Influences
2018 - Wiley | European Management Review
Eytan Mor, Burt R. Meyers, Özgür Yağmur, Keiji Kishikawa, Patricia A. Sheiner, Sukru Emre, Myron Schwartz, Charles M. Miller,
We attempted to prevent cytomegalovirus (CMV) disease in liver transplant (LTx) recipients by means of a combined prophylaxis regimen consisting of high-dose acyclovir (HDA) and immune globulin (IVIG). In 259 consecutive patients, HDA was given for 3 months post-LTx; recipients seronegative for CMV also received IVIG. The previous 94 patients comprised our control group; in this group, low dose acyclovir was given to prevent herpes, and prophylaxis of CMV consisted of IVIG given only to seronegative ...
Tópico(s): Herpesvirus Infections and Treatments
1995 - Springer Science+Business Media | Transplant International
Eytan Mor, Burt R. Meyers, Özgür Yağmur, Keiji Kishikawa, Patricia A. Sheiner, Sukru Emre, Myron Schwartz, Charles M. Miller,
Abstract We attempted to prevent cytomegalovirus (CMV) disease in liver transplant (LTx) recipients by means of a combined prophylaxis regimen consisting of high-dose acyclovir (HDA) and immune globulin (IVIG). In 259 consecutive patients, HDA was given for 3 months post-LTx; recipients seronegative for CMV also received IVIG. The previous 94 patients comprised our control group; in this group, low dose acyclovir was given to prevent herpes, and prophylaxis of CMV consisted of IVIG given only to seronegative ...
Tópico(s): Herpesvirus Infections and Treatments
1995 - Springer Science+Business Media | Transplant International
Ekin Emre ERKILIÇ, Neriman Mor, Ali Haydar KIRMIZIGÜL,
Dirofilariasis is a vector-borne disease which is zoonotic. The aim of this study was to determine the seroprevalence of dirofilariasis in indoor cats with outdoor access in the centre and districts of the Kars province. Blood samples were collected from a total of 150 cats, including 71 males and 79 females. The localities selected for sampling were the centre of the Kars province (n=78), and the districts Sarıkamış (n=30), Arpaçay (n=24) and Selim (n=18). Dirofilariasis seropositivity was 29.5% in ...
Tópico(s): Parasites and Host Interactions
2019 - Polish Society of Veterinary Sciences | Medycyna Weterynaryjna
Evren Atillasoy, Alihan Gürkan, Eytan Mor, G Altaca, Patricia A. Sheiner, Stephen R. Guy, Myron Schwartz, Crystal Miller, P D Berk, Sukru Emre,
Background: With current early transplant patient and allograft survivals nearly optimized, long-term medical complications have become a significant focus for potential improvement in patient outcomes. Cardiovascular disease and associated risk factors have been shown in renal transplant patients to be related to the pharmacologic immunosuppression employed.Objective: The objective of this study is to investigate at 3 years postliver transplant (OLTx) the incidence of hypertension (HTN), hyperlipidemia ( ...
Tópico(s): Organ Transplantation Techniques and Outcomes
1998 - Elsevier BV | Transplantation Proceedings